David J. Wambeke

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Emily Johns, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Wambeke:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Business Officer Voting Common Shares, no par value per share 527,114 $1,945,050 $3.69 01 Jun 2025 Direct
DiaMedica Therapeutics Inc. Chief Business Officer Voting Common Shares, no par value per share 527,114 $1,475,919 $2.80 01 Jun 2024 Direct
NEUROONE MEDICAL TECHNOLOGIES Corp Chief Business Officer Common Stock 1,000,000 $670,400 $0.6704 01 Mar 2026 Direct
NEUROONE MEDICAL TECHNOLOGIES Corp Chief Business Officer Option to Purchase Common Stock 500,000 01 Mar 2026 Direct
DiaMedica Therapeutics Inc. Chief Business Officer Stock Option (right to buy) 250,000 01 Jun 2025 Direct

Insider Reports Filed by David J. Wambeke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp 01 Mar 2026 2 +$670,400 4 Chief Business Officer 03 Mar 2026, 08:49
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp 01 Mar 2026 0 $0 3 Chief Business Officer 03 Mar 2026, 08:39
DMAC DiaMedica Therapeutics Inc. 01 Jun 2025 1 $0 4 Chief Business Officer 03 Jun 2025, 16:19
DMAC DiaMedica Therapeutics Inc. 01 Jun 2024 1 $0 4 Chief Business Officer 03 Jun 2024, 17:06
DMAC DiaMedica Therapeutics Inc. 16 Nov 2023 1 +$49,200 4 Chief Business Officer 16 Nov 2023, 16:37
DMAC DiaMedica Therapeutics Inc. 23 Jun 2023 1 +$150,003 4 Chief Business Officer 26 Jun 2023, 16:14
DMAC DiaMedica Therapeutics Inc. 10 Apr 2023 2 +$750,000 4 Chief Business Officer 11 Apr 2023, 17:40
DMAC DiaMedica Therapeutics Inc. 10 Apr 2023 0 $0 3 Chief Business Officer 11 Apr 2023, 17:34